Archive Newsletter

11. 04.02.25 -- Understanding The New MHRA Guidance For mRNA Immunotherapies 4/2/2025
    04/02/25 Advancing RNA Newsletter
12. 03.26.25 -- The mRNA Industry's 3 Big Wishes For CDMOs 3/26/2025
    03/26/25 Advancing RNA Newsletter
13. 03.24.25 -- Oncology CRO Services 3/24/2025
    03/24/25 Advancing RNA Newsletter
14. 03.21.25 -- Advancements In The Global Clinical Trial Landscape 3/21/2025

    03/21/25 Advancing RNA Newsletter

15. 03.19.25 -- DNA Quality For IVT: What Do We (Really) Know? 3/19/2025
    03/19/25 Advancing RNA Newsletter
16. 03.18.25 -- Exploring The Benefits Of Novel Nucleases In CRISPR Therapies 3/18/2025

    03/18/25 Advancing RNA Newsletter

17. 03.12.25 -- How Are The Costs Of mRNA-LNP Manufacturing Evolving? 3/12/2025
    03/12/25 Advancing RNA Newsletter
18. 03.05.25 -- The Latest & Greatest Innovations In mRNA-LNP production 3/5/2025
    03/05/25 Advancing RNA Newsletter
19. 02.26.25 -- IP Considerations For Early-Stage mRNA Therapeutics Development 2/26/2025
    02/26/25 Advancing RNA Newsletter
20. 02.24.25 -- How To Best Optimize mRNA Production Workflows 2/24/2025
    02/24/25 Advancing RNA Newsletter